# A Pilot Study of Topiramate in Childhood Absence Epilepsy

> **NCT00210574** · PHASE2 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 12 (actual)

## Conditions studied

- Epilepsy, Absence

## Interventions

- **DRUG:** topiramate

## Key facts

- **NCT ID:** NCT00210574
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2011-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00210574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00210574, "A Pilot Study of Topiramate in Childhood Absence Epilepsy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00210574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*